INmune Bio, Inc. (INMB) Misses Q3 EPS by 8c

INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.60), $0.08 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Playboy to buy back 16.6M shares from Fortress at $1.05 each
• Ennis (EBF) Reports In-Line Q1 EPS
• ITG targets $2.67 billion valuation in U.S. IPO